LAS VEGAS — In this Healio Video Perspective from the ASCRS meeting, Eric D. Donnenfeld, MD, discusses the FDA phase 2 trial of risuteganib in patients with dry eye disease.
Uncategorized
VIDEO: Donnenfeld discusses risuteganib for dry eye disease